Home › NCT04891510
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
Recruiting
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Female; * Documented history of previous breast surgery (either complete or partial mastectomy); * Available harvest sites for fat grafting as documented by plastic surgeon; * BMI \> 20; * Anticipated harvested fat volume \> 50cc; * Competency and willingness to provide consent Exclusion Criteria: * Suspected or known to be pregnant
About the study
The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.
What is being tested
- REVOLVE Advanced Adipose System (device)
- LipoGrafter (device)
- Viality (procedure)
Sponsor: Weill Medical College of Cornell University · Participants: 135 · Started: May 19, 2021
Contact the study team
- Michael B Amrami, MPH · Phone: 646-544-7658
- Daana Bajnauth · Phone: 646-789-1447
Official record on ClinicalTrials.gov — NCT04891510
Locations in the U.S.
| New York | New York Presbyterian - Weill Cornell Medicine, New York |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.